A
REGN icon

Allianz’s Regeneron Pharmaceuticals REGN Stock Holding History

Allianz’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
+31
New +$21.1K ﹤0.01% 463
2026
Q1 		– Sell
-892
Closed -$689K – 493
2025
Q4 		$689K Buy
+892
New +$606K 0.01% 279
2025
Q2 		– Sell
-65
Closed -$41.2K – 435
2025
Q1 		$41.2K Sell
65
-70
-52% -$48.1K ﹤0.01% 360
2024
Q4 		$96.2K Sell
135
-1,191
-90% -$1,000K ﹤0.01% 362
2024
Q3 		$1.39M Buy
1,326
+843
+175% +$938K 0.04% 202
2024
Q2 		$508K Sell
483
-723
-60% -$701K 0.01% 274
2024
Q1 		$1.16M Buy
+1,206
New +$1.15M 0.04% 211

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Allianz's REGN Position: Q2 2026 in Review

Allianz opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 31 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #463 among its holdings. This is a return to the name: Allianz previously reported a position in REGN as recently as Q4 2025.

Allianz first reported a position in REGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.39M in Q3 2024. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Allianz held 31 shares of Regeneron Pharmaceuticals worth $19.3K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Allianz position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #463 holding.
  • Allianz first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Allianz's Regeneron Pharmaceuticals position peaked at $1.39M in Q3 2024.
  • 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.